ACUTE LYMPHOBLASTIC LEUKAEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Tough-to-Treat blood cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new oral drug called AZD3632 for people with advanced blood cancers like leukemia and myelodysplastic syndromes that have returned or stopped responding to standard treatments. The main goals are to find a safe dose, see how the body processes …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First patients dosed in early trial for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of an experimental drug called CC312 for adults with certain B-cell blood cancers that have come back or stopped responding to other therapies. The main goal is to check the drug's safety and how the body processes it in about 44…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC